These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34383713)

  • 1. TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis.
    Varricchio L; Iancu-Rubin C; Upadhyaya B; Zingariello M; Martelli F; Verachi P; Clementelli C; Denis JF; Rahman AH; Tremblay G; Mascarenhas J; Mesa RA; O'Connor-McCourt M; Migliaccio AR; Hoffman R
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34383713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hmga2 promotes the development of myelofibrosis in Jak2
    Dutta A; Hutchison RE; Mohi G
    Blood; 2017 Aug; 130(7):920-932. PubMed ID: 28637665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ALK5 inhibition in myelofibrosis.
    Yue L; Bartenstein M; Zhao W; Ho WT; Han Y; Murdun C; Mailloux AW; Zhang L; Wang X; Budhathoki A; Pradhan K; Rapaport F; Wang H; Shao Z; Ren X; Steidl U; Levine RL; Zhao ZJ; Verma A; Epling-Burnette PK
    JCI Insight; 2017 Apr; 2(7):e90932. PubMed ID: 28405618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis.
    Mascarenhas J; Migliaccio AR; Kosiorek H; Bhave R; Palmer J; Kuykendall A; Mesa R; Rampal RK; Gerds AT; Yacoub A; Pettit K; Talpaz M; Komrokji R; Kremyanskaya M; Gonzalez A; Fabris F; Johnson K; Dougherty M; McGovern E; Arango Ossa J; Domenico D; Farnoud N; Weinberg RS; Kong A; Najfeld V; Vannucchi AM; Arciprete F; Zingariello M; Falchi M; Salama ME; Mead-Harvey C; Dueck A; Varricchio L; Hoffman R
    Clin Cancer Res; 2023 Sep; 29(18):3622-3632. PubMed ID: 37439808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.
    Ozono Y; Shide K; Kameda T; Kamiunten A; Tahira Y; Sekine M; Akizuki K; Nakamura K; Iwakiri H; Sueta M; Hidaka T; Kubuki Y; Yamamoto S; Hasuike S; Sawaguchi A; Nagata K; Shimoda K
    Leukemia; 2021 Feb; 35(2):454-467. PubMed ID: 32472085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia.
    Rodríguez A; Yang C; Furutani E; García de Teresa B; Velázquez M; Filiatrault J; Sambel LA; Phan T; Flores-Guzmán P; Sánchez S; Monsiváis Orozco A; Mayani H; Bolukbasi OV; Färkkilä A; Epperly M; Greenberger J; Shimamura A; Frías S; Grompe M; Parmar K; D'Andrea AD
    Exp Hematol; 2021 Jan; 93():70-84.e4. PubMed ID: 33166613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis.
    Zingariello M; Martelli F; Ciaffoni F; Masiello F; Ghinassi B; D'Amore E; Massa M; Barosi G; Sancillo L; Li X; Goldberg JD; Rana RA; Migliaccio AR
    Blood; 2013 Apr; 121(17):3345-63. PubMed ID: 23462118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Role and Therapeutic Targeting of TGF-β
    Seystahl K; Papachristodoulou A; Burghardt I; Schneider H; Hasenbach K; Janicot M; Roth P; Weller M
    Mol Cancer Ther; 2017 Jun; 16(6):1177-1186. PubMed ID: 28377490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.
    Ciaffoni F; Cassella E; Varricchio L; Massa M; Barosi G; Migliaccio AR
    Blood Cells Mol Dis; 2015 Mar; 54(3):234-41. PubMed ID: 25703685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Variation in the Traits Ameliorated by Inhibitors of JAK1/2, TGF-β, P-Selectin, and CXCR1/CXCR2 in the
    Gobbo F; Martelli F; Di Virgilio A; Demaria E; Sarli G; Migliaccio AR
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice.
    Capitano M; Zhao L; Cooper S; Thorsheim C; Suzuki A; Huang X; Dent AL; Marks MS; Abrams CS; Broxmeyer HE
    Blood; 2018 Sep; 132(10):1027-1038. PubMed ID: 30042096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice.
    Chagraoui H; Komura E; Tulliez M; Giraudier S; Vainchenker W; Wendling F
    Blood; 2002 Nov; 100(10):3495-503. PubMed ID: 12393681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
    Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of embryonic tendon-like tissue by human marrow stromal/mesenchymal stem cells requires a three-dimensional environment and transforming growth factor β3.
    Kapacee Z; Yeung CY; Lu Y; Crabtree D; Holmes DF; Kadler KE
    Matrix Biol; 2010 Oct; 29(8):668-77. PubMed ID: 20736064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis.
    Vannucchi AM; Bianchi L; Paoletti F; Pancrazzi A; Torre E; Nishikawa M; Zingariello M; Di Baldassarre A; Rana RA; Lorenzini R; Alfani E; Migliaccio G; Migliaccio AR
    Blood; 2005 May; 105(9):3493-501. PubMed ID: 15665119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
    Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
    Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation.
    Khanlari M; Wang X; Loghavi S; Wang SA; Li S; Thakral B; Bueso-Ramos CE; Yin CC; Kanagal-Shamanna R; Khoury JD; Patel KP; Popat UR; Medeiros LJ; Konoplev S
    Ann Diagn Pathol; 2022 Feb; 56():151860. PubMed ID: 34823075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells.
    Chen Z; Li DQ; Tong L; Stewart P; Chu C; Pflugfelder SC
    Mol Vis; 2006 Aug; 12():983-94. PubMed ID: 16943770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.